GLOW Peptide Blend Vial Size: Reconstitution Math

GLOW peptide blend vial size is a supply question, not a draw-math question: how much total GHK-Cu, BPC-157, and TB-500 does a given vial actually contain, and how far does that stretch across a protocol? Vial size is fixed at manufacture and printed in milligrams on the label, but what it means day to day depends on the target dose and the water volume chosen at reconstitution. This guide separates what vial size does and doesn't determine for a GLOW blend. It is a research reference, not medical advice.

Common GLOW vial sizes

GLOW ships as GHK-Cu, BPC-157, and TB-500 premixed in one lyophilized vial, and research suppliers commonly offer it at two totals:

Vial size	Composition (5:1:1 ratio)
35 mg	25 mg GHK-Cu / 5 mg BPC-157 / 5 mg TB-500
70 mg	50 mg GHK-Cu / 10 mg BPC-157 / 10 mg TB-500

Both sizes hold the same 5:1:1 split between the three peptides — a 35 mg vial is simply half of a 70 mg vial's content, not a different formula. Labeling isn't standardized across every supplier, so treat these two figures as common reference points and always confirm the actual mg total on your own vial before running any calculation.

Vial size sets total mg, not the size of one draw

The point worth separating out first: vial size determines how many total milligrams of blend you have to work with across the whole vial, not how large any single draw is. A 2 mg dose is a 2 mg dose whether it comes from a 35 mg vial or a 70 mg vial. What changes is how many 2 mg draws the vial can supply before it's empty. That relationship is one division:

Doses per vial = vial mass (mg) ÷ target dose (mg)

Worked example: doses per vial

Compare the two common sizes at a fixed 2 mg target dose:

• 35 mg vial: 35 ÷ 2 = 17.5 doses
• 70 mg vial: 70 ÷ 2 = 35 doses

Doubling the vial size exactly doubles the doses available, since the target dose didn't change. Notice the 35 mg vial doesn't divide evenly here — the 18th draw would only have 1 mg of blend left in the vial, half of a full 2 mg dose. That leftover fraction is a property of the vial size and dose size only; it has nothing to do with how much water was added.

Vial size and the fixed component ratio

A GLOW vial adds one wrinkle a single-peptide vial doesn't have: every draw splits across three compounds at a fixed 5:1:1 ratio, and that split holds regardless of which vial size it came from. Take the same 2 mg draw from either vial:

• GHK-Cu: 2 mg × (5 ÷ 7) ≈ 1.43 mg
• BPC-157: 2 mg × (1 ÷ 7) ≈ 0.29 mg
• TB-500: 2 mg × (1 ÷ 7) ≈ 0.29 mg

Those three figures sum back to the 2 mg total, and they come out identical whether the vial was 35 mg or 70 mg. Vial size changes the count of draws remaining in the vial. It never changes the proportion of GHK-Cu, BPC-157, and TB-500 inside any single draw — that proportion is fixed the moment the vial was lyophilized.

Water volume changes the draw, not the count

Vial size and water volume are separate variables, and it's easy to conflate them. Reconstitute a 35 mg vial two different ways and compare a 1 mg draw:

Vial size	Water added	Concentration	1 mg dose (units, U-100)	Doses per vial
35 mg	1.5 mL	≈23.3 mg/mL	≈4.3 units	35
35 mg	1 mL	35 mg/mL	≈2.9 units	35

Step through the second row. Concentration: 35 mg ÷ 1 mL = 35 mg/mL. Draw volume: 1 mg ÷ 35 mg/mL = 0.0286 mL. Syringe units on a U-100 insulin syringe (1 mL = 100 units): 0.0286 mL × 100 ≈ 2.9 units. Both rows come from the same 35 mg vial and the same 1 mg target dose, so both hold exactly 35 doses at that dose size. Only the unit reading on the syringe moved — a question of which mark is easier to draw accurately, not a question of supply.

Matching vial size to protocol length

Sizing a vial (or several) to a planned protocol is the same formula worked backward:

Total mg needed = number of planned doses × dose size (mg)

Worked example. A protocol calling for a 2 mg dose once daily for five weeks runs 35 days, so it needs 35 doses. Total mg required: 35 × 2 mg = 70 mg. A single 70 mg GLOW vial covers this exactly, with none left over. Working from 35 mg vials instead, two are needed to reach that same 70 mg total — each supplying 17.5 doses, 35 combined. Running this arithmetic before ordering turns "which vial size should I buy" into a total-mg question with one answer, rather than a guess.

Common mistakes

• Assuming a bigger vial means a bigger single dose. Vial size sets total supply; the target dose sets the size of each draw.
• Forgetting that water volume doesn't change how many doses a vial holds. It changes the mL and unit reading per draw, not the count of draws remaining.
• Applying a single-peptide vial's sizing logic without adjusting for the blend total. A 70 mg GLOW vial and a 70 mg single-peptide vial both hold 70 mg, but the GLOW vial splits that mass three ways at 5:1:1.
• Ordering by vial count instead of total mg. Two 35 mg vials and one 70 mg vial contain the same total blend — plan around milligrams, not the number of vials in the box.

Evidence level

GHK-Cu, BPC-157, and TB-500 are each studied individually in preclinical research — largely animal models and in-vitro work — rather than large controlled human trials. None of the three is FDA-approved for human use, and packaging them together into a GLOW vial of any size doesn't change that evidence picture for any individual component. Treat GLOW, in either common vial size, as a research compound rather than a proven human therapeutic.

Use the calculator

The doses-per-vial arithmetic above is two divisions and doesn't need a tool. Where a tool earns its keep is the per-draw conversion: enter your vial's actual total mg, the water volume you added, and a target dose into the peptide dosage calculator to get the exact mL and syringe units for that draw, or run reverse mode to find the water volume that lands a dose on a whole unit mark. For the component-ratio math behind a GLOW draw, see the GLOW peptide blend dosage guide. For the same vial-size logic applied to a single-peptide vial, see the GHK-Cu vial size guide.